Melanotan II generates more Reddit and ThinkSteroids posts than any other cosmetic peptide — and more GI signaling response reports per researcher than any compound in the peptide community. Understanding why requires understanding MC receptor promiscuity.
The Receptor Problem
MT-2 is a non-selective melanocortin receptor agonist. It binds MC1R (pigmentation — the desired effect), MC3R (energy homeostasis, GI motility — the GI signaling response), MC4R (MC4R-mediated response, appetite signaling — the MC4R-mediated responses, the appetite signaling suppression), and MC5R (exocrine glands — the flushing). You cannot activate MC1R without also hitting MC3R and MC4R. The GI signaling response is not an allergic reaction. It is on-target pharmacology at an off-target receptor.
The 0.25 mg Sweet Spot
The community's most persistent MT-2 myth: "darker skin requires higher test parameters." The ED50 for melanogenesis is approximately 50 mcg. At 0.25 mg versus 0.5 mg, final melanin saturation differs by less than 10%, but GI signaling response rates drop by 60%. The concentration-response curve for pigmentation plateaus early; the concentration-response curve for GI signaling response does not. 0.25 mg is the evidence-based sweet spot. Titrate up from 0.1 mg over 10-14 days, and never exceed 1.0 mg per application.
Nasal Spray: Worse, Not Better
Community feedback consistently shows that intranasal MT-2 produces higher GI signaling response rates than research model application, despite lower bioavailability (25-30% of applied test parameter). The mechanism: erratic nasal absorption creates unpredictable plasma concentration spikes that acutely trigger MC4R — a sharp peak triggers a more pronounced GI signaling response than a smooth research model absorption curve. Stick to research model application for test parameter precision.
Absolute contraindication: Personal or family history of melanoma. MC1R overactivation in the context of pre-existing melanocytic dysplasia is a risk profile that no research protocol should accept. This is not conservatism — it is the one contraindication the community unanimously endorses.
Ourovia recommendation: MT-2 requires a cyclic protocol: 3-month loading phase → 3-month washout → reassessment before continuation. Combine with SPF 50+ physical sunscreen — MT-2-induced melanin synthesis is triggered by as little as 10 minutes of UVA exposure, and the melanin, once deposited, remains visible for weeks regardless of subsequent sun protection.
